Success Metrics

Clinical Success Rate
75.0%

Based on 3 completed trials

Completion Rate
75%(3/4)
Active Trials
2(22%)
Results Posted
33%(1 trials)
Terminated
1(11%)

Phase Distribution

Ph phase_1
1
11%
Ph phase_2
4
44%
Ph not_applicable
2
22%
Ph phase_4
1
11%
Ph phase_3
1
11%

Phase Distribution

1

Early Stage

4

Mid Stage

2

Late Stage

Phase Distribution9 total trials
Phase 1Safety & dosage
1(11.1%)
Phase 2Efficacy & side effects
4(44.4%)
Phase 3Large-scale testing
1(11.1%)
Phase 4Post-market surveillance
1(11.1%)
N/ANon-phased studies
2(22.2%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

60.0%

3 of 5 finished

Non-Completion Rate

40.0%

2 ended early

Currently Active

2

trials recruiting

Total Trials

9

all time

Status Distribution
Active(2)
Completed(3)
Terminated(2)
Other(2)

Detailed Status

Completed3
unknown2
Recruiting2
Withdrawn1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
2
Success Rate
75.0%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (11.1%)
Phase 24 (44.4%)
Phase 31 (11.1%)
Phase 41 (11.1%)
N/A2 (22.2%)

Trials by Status

unknown222%
withdrawn111%
terminated111%
recruiting222%
completed333%

Recent Activity

2 active trials
Showing 5 of 9
recruitingphase_2

Enhanced Dermatological Care to Reduce Rash and Paronychia in Epidermal Growth Factor Receptor (EGRF)-Mutated Non-Small Cell Lung Cancer (NSCLC) Treated First-line With Amivantamab Plus Lazertinib

NCT06120140
recruitingphase_2

Early Intervention in Plaque Psoriasis: is Bimekizumab Able to Delay Chronic Inflammation?

NCT06742333
completedphase_2

A Comparison of Photodynamic Therapy and Topical Clobetasol in Treatment of Oral Lichen Planus: a Split-Mouth Randomised Controlled Study

NCT06752343
withdrawnphase_1

Comparative Effectiveness Trial in the Treatment of Pediatric Plaque Morphea

NCT02680717
terminatednot_applicable

Mechanistically-based Optimization of UV Radiation Therapy in Psoriasis

NCT00470392
View all 9 trials

Clinical Trials (9)

Showing 9 of 9 trials
NCT06120140Phase 2

Enhanced Dermatological Care to Reduce Rash and Paronychia in Epidermal Growth Factor Receptor (EGRF)-Mutated Non-Small Cell Lung Cancer (NSCLC) Treated First-line With Amivantamab Plus Lazertinib

Recruiting
NCT06742333Phase 2

Early Intervention in Plaque Psoriasis: is Bimekizumab Able to Delay Chronic Inflammation?

Recruiting
NCT06752343Phase 2

A Comparison of Photodynamic Therapy and Topical Clobetasol in Treatment of Oral Lichen Planus: a Split-Mouth Randomised Controlled Study

Completed
NCT02680717Phase 1

Comparative Effectiveness Trial in the Treatment of Pediatric Plaque Morphea

Withdrawn
NCT00470392Not Applicable

Mechanistically-based Optimization of UV Radiation Therapy in Psoriasis

Terminated
NCT01987076Not Applicable

Comparison Between Corticosteroid and Topical Steroids in the DRESS

Unknown
NCT01699412Phase 3

Clinical Trial With Clobetasol and Dexamethasone for Topical Treatment of Oral Lesions of Chronic Graft-versus-host Disease

Completed
NCT00715975Phase 2

Effectiveness and Safety of Topical Halobetasol Propionate in the Treatment of Patients With Psoriasis

Completed
NCT00779792Phase 4

Efficacy of Glycerol, Two Topical Steroids, and a Topical Immune Modulator Against Skin Irritation

Unknown

All 9 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
9